You are subscribed to the Drug Topics Hospital Pharmacists' Report.

Drug Topics Hospital Pharmacists' Report

Print Subscribe

Digital Edition Subscribe

February 21, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

ISMP warns of unsafe insulin pen use

The Institute for Safe Medication Practices is advising hospitals not to use insulin pens for the routine care of patients. This warning is in response to a report that more than 700 patients at a New York hospital may have been exposed to HIV, hepatitis B, or hepatitis C after insulin pens were reused on multiple patients. » More

Continuing Education

New CPE Series: February activity available now

Welcome to the sixth activity in our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The February activity covers psychosocial considerations in the management of diabetes.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

TODAY'S HEADLINES

What to do about multidrug-resistant gonorrhea

The Centers for Disease Control and Prevention (CDC) acknowledges that gonorrhea is a growing U.S. public health problem because of its prevalence and lack of effective treatment options. Recently, CDC updated its treatment recommendations for the disease. » More

FDA approves new multiple myeloma drug with REMS

FDA has approved pomalidomide (Pomalyst, Celgene) to treat patients with multiple myeloma. Because of the drug's embryo-fetal risk, however, it is only available through a Risk Evaluation and Mitigation Strategy program. » More

New ACOs serve more patients throughout the country

The U.S. Department of Health & Human Services recently announced the approval of 106 new accountable care organizations into the Medicare Shared Savings Program. » More

TAKE OUR SURVEY

New guidelines for managing type 2 diabetes in children and adolescents were released by the American Academy of Pediatrics.

How knowledgeable are you in managing this disease state in this population?

- Very knowledgeable
- Somewhat knowledgeable
- Little to no knowledge

Click Here to let us know.

 

Check these out too

FDA approves organ rejection drug

New AAP guidelines for kids with T2DM

DEA's controlled substances proposal

Calcium may increase CVD risk in men

Voices

Anticoagulation Update

JP at Large: You are a pharmacist, right?

View from the Zoo: Unmeasurable conversations. Priceless

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News and analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group